"Cell Dedifferentiation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reverse developmental process in which terminally differentiated cells with specialized functions revert back to a less differentiated stage within their own CELL LINEAGE.
Descriptor ID |
D054337
|
MeSH Number(s) |
G04.148
|
Concept/Terms |
Cell Dedifferentiation- Cell Dedifferentiation
- Cell Dedifferentiations
- Dedifferentiations, Cell
- Dedifferentiation, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Dedifferentiation".
Below are MeSH descriptors whose meaning is more specific than "Cell Dedifferentiation".
This graph shows the total number of publications written about "Cell Dedifferentiation" by people in this website by year, and whether "Cell Dedifferentiation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 1 | 2 |
2010 | 1 | 3 | 4 |
2011 | 0 | 2 | 2 |
2012 | 1 | 2 | 3 |
2013 | 1 | 3 | 4 |
2015 | 2 | 2 | 4 |
2016 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 5 | 6 |
2019 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
2021 | 0 | 2 | 2 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Dedifferentiation" by people in Profiles.
-
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. Oncologist. 2024 May 03; 29(5):392-399.
-
Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation. Circulation. 2024 Jun 04; 149(23):1833-1851.
-
From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature. Ann Diagn Pathol. 2021 Jun; 52:151720.
-
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer Gene Ther. 2021 12; 28(12):1325-1338.
-
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. Urol Oncol. 2021 02; 39(2):134.e9-134.e16.
-
Hemogenic Endothelial Cells Can Transition to Hematopoietic Stem Cells through a B-1 Lymphocyte-Biased State during Maturation in the Mouse Embryo. Stem Cell Reports. 2019 07 09; 13(1):21-30.
-
Notch signaling in bone marrow-derived FSP-1?cells initiates neointima formation in arteriovenous?fistulas. Kidney Int. 2019 06; 95(6):1347-1358.
-
Anti-M?llerian hormone (AMH) regulates stemness-promoting factors in fresh and previously vitrified-warmed ovarian cortex. Minerva Ginecol. 2019 Jun; 71(3):249-253.
-
Dedifferentiated gastrointestinal stromal tumor: Recent advances. Ann Diagn Pathol. 2019 Apr; 39:118-124.
-
Cellular Plasticity of Defa4Cre-Expressing Paneth Cells in Response to Notch Activation and Intestinal Injury. Cell Mol Gastroenterol Hepatol. 2019; 7(3):533-554.